Cargando…
Significance of Methylation of FBP1 Gene in Non-Small Cell Lung Cancer
Because NSCLC has poor overall prognosis and is frequently diagnosed at later stage, we aimed to seek novel diagnosis biomarkers or therapy target of the disease in this study. Fructose-1,6-bisphosphatase 1 (FBP1) is a rate-limiting enzyme in gluconeogenesis, which was usually lost in NSCLC due to a...
Autores principales: | Dong, Yao, Huaying, Sheng, Danying, Wan, Chihong, Zhu, Ruibin, Jiang, Xiaojiang, Sun, Jianguo, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015716/ https://www.ncbi.nlm.nih.gov/pubmed/29984231 http://dx.doi.org/10.1155/2018/3726091 |
Ejemplares similares
-
Prognostic value of transglutaminase 2 in non-small cell lung cancer patients
por: Chihong, Zhu, et al.
Publicado: (2017) -
Correlation of neuroendocrine features with prognosis of non-small cell lung cancer
por: Feng, Jianguo, et al.
Publicado: (2016) -
Effect of Adjuvant Magnetic Fields in Radiotherapy on Non-Small-Cell Lung Cancer Cells In Vitro
por: Feng, Jianguo, et al.
Publicado: (2013) -
Therapy Effects of Wogonin on Ovarian Cancer Cells
por: Ruibin, Jiang, et al.
Publicado: (2017) -
Transglutaminase 2 Inhibitor KCC009 Induces p53-Independent Radiosensitization in Lung Adenocarcinoma Cells
por: Huayin, Sheng, et al.
Publicado: (2016)